Researchers discovered that a type of junk DNA in mosquitoes orchestrates the start of their life by regulating the activity of other RNA molecules. The breakdown of maternal RNA is essential for further development and is controlled by the stuttering DNA.
Researchers at Radboud University Medical Center developed an AI system that accurately diagnoses prostate cancer aggressiveness using deep learning. The system performed better than ten human pathologists and provided consistent results, reducing the need for subjective Gleason scoring.
A randomized trial at a music festival in the Netherlands found that virtual reality (VR) training was comparable to traditional hands-on training for cardiopulmonary resuscitation (CPR) skills. The study, which enrolled 381 participants, showed improved results for speed and depth of compressions in both groups.
A new pantothenamide molecule, closely resembling a naturally occurring compound in malaria parasites, has shown promising results as a potential cure for the disease. Laboratory models suggest a single dose of the candidate drug may completely cure malaria, making it an attractive alternative to existing treatments.
A recent study by Radboud University Medical Center found that exercising at home using motivating apps significantly improves cardiovascular fitness and motor disability in Parkinson's patients. The cycling exercise program was more effective than stretching exercises alone, with a notable impact on disease progression.
Researchers found a significant association between elevated post-exercise troponin levels and an increased risk of severe cardiovascular disease or death. The study suggests that exercise may serve as a stress test for the heart, allowing for early identification of susceptible individuals who require closer monitoring.
Researchers at Radboud University Medical Center found that septoplasty significantly improves patients' quality of life by increasing nasal airflow and reducing symptoms. After two years, the positive effects persisted, indicating a long-term benefit from the procedure.
A recent study found that lowering cholesterol with statins does not decrease the activation of immune cells in patients with high cholesterol levels. This 'trained immunity' allows immune cells to 'remember' previous exposures and maintain hyperactivity despite cholesterol reduction.
Researchers have identified novel antigens on infected red blood cells that trigger natural human antibody responses, reducing malaria transmission. The discovery provides a promising alternative route for preventing disease spread and offers new leads for developing effective vaccines.
Researchers identified a new genetic cause of multi-tumor syndrome, which increases lifetime risk for patients with colorectal and breast cancers. The study found that rare NTHL1 gene mutations lead to the development of both diseases.
Researchers found large differences in brain regions among individuals with schizophrenia, making it difficult to diagnose based on symptoms. The study highlights the need for individualized treatments and brain 'fingerprints' to improve patient outcomes.
Researchers have determined the entire DNA sequence of pneumococci isolated from patient blood, relating genetic variation to over twenty disease manifestations. The study identified specific bacterial genes linked to infection severity and mortality, providing new diagnostic tools.
A targeted 'click-to-release' chemotherapy approach has shown promising results in mice, demonstrating effective anticancer effects against ovarian and colon cancers. The innovative method, developed by Tagworks Pharmaceuticals, releases a large quantity of chemotherapy drug quickly, attacking the tumor cells.
Researchers at Radboud University Medical Center have identified a unique protein in the malaria parasite's mitochondrion that could be targeted for a new vaccine. The protein, known as 'prohibitin,' plays a crucial role in the parasite's survival and is not present in human cells.
A large-scale study of 1,800 ICU patients found that prophylactic haloperidol use does not prevent delirium or improve survival rates. The study, published in JAMA, suggests that administering haloperidol as a preventive measure is unnecessary and may even increase the risk of complications.